We are live on ! Find out more
CA

Callahan Advisors Portfolio holdings

AUM $1.33B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+7.95%
1 Year Est. Return
+29.71%
3 Year Est. Return
+87.75%
5 Year Est. Return
+121.89%
10 Year Est. Return
+408.77%
AUM
$823M
AUM Growth
+$48.7M
Cap. Flow
-$2.36M
Cap. Flow %
-0.29%
Top 10 Hldgs %
32.47%
Holding
142
New
7
Increased
62
Reduced
51
Closed
9

Top Buys

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$3.78M
2
BN icon
Brookfield
BN
+$2.26M
3
CFR icon
Cullen/Frost Bankers
CFR
+$1.93M
4
CAT icon
Caterpillar
CAT
+$1.64M
5
DEO icon
Diageo
DEO
+$1.23M

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$4.2M
2
ABBV icon
AbbVie
ABBV
+$4.01M
3
AAPL icon
Apple
AAPL
+$2.25M
4
TSN icon
Tyson Foods
TSN
+$2.25M
5
ENB icon
Enbridge
ENB
+$2.23M

Sector Composition

Rank Sector Weight
1 Technology 18.43%
2 Healthcare 14.98%
3 Financials 11.87%
4 Communication Services 10.23%
5 Consumer Discretionary 10.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
26
Pfizer
PFE
$143B
$11.8M 1.43%
321,248
+2,662
+0.8% +$104K
WMT icon
27
Walmart Inc
WMT
$881B
$11M 1.33%
209,028
+1,962
+0.9% +$99K
ACN icon
28
Accenture
ACN
$101B
$10.3M 1.26%
33,499
+463
+1% +$135K
EOG icon
29
EOG Resources
EOG
$77.6B
$10.2M 1.25%
89,530
+4,726
+6% +$540K
ABT icon
30
Abbott
ABT
$185B
$9.77M 1.19%
89,615
-2,092
-2% -$223K
STE icon
31
Steris
STE
$22.7B
$9.19M 1.12%
40,864
+1,543
+4% +$309K
FTNT icon
32
Fortinet
FTNT
$120B
$9.1M 1.11%
120,390
+15,885
+15% +$1.08M
PAYX icon
33
Paychex
PAYX
$41.9B
$8.85M 1.08%
79,087
+1,167
+1% +$128K
DIS icon
34
Walt Disney
DIS
$170B
$8.82M 1.07%
98,818
-532
-0.5% -$50.4K
BHP icon
35
BHP
BHP
$212B
$8.78M 1.07%
147,179
-4,177
-3% -$249K
CTVA icon
36
Corteva
CTVA
$50.9B
$8.78M 1.07%
153,148
+10,578
+7% +$617K
KMI icon
37
Kinder Morgan
KMI
$69.9B
$8.65M 1.05%
502,553
-14,344
-3% -$244K
DEO icon
38
Diageo
DEO
$49.2B
$8.35M 1.01%
48,137
+6,906
+17% +$1.23M
NKE icon
39
Nike
NKE
$63.3B
$7.57M 0.92%
68,568
-1,434
-2% -$168K
BKNG icon
40
Booking.com
BKNG
$149B
$7.44M 0.9%
68,925
+6,800
+11% +$719K
SLB icon
41
SLB Ltd
SLB
$73.2B
$7.26M 0.88%
147,898
+11,303
+8% +$539K
CVS icon
42
CVS Health
CVS
$134B
$6.98M 0.85%
101,039
+12,935
+15% +$920K
URI icon
43
United Rentals
URI
$69.5B
$6.61M 0.8%
14,840
+2,284
+18% +$846K
IQV icon
44
IQVIA
IQV
$38.4B
$6.61M 0.8%
29,403
+2,704
+10% +$543K
GPN icon
45
Global Payments
GPN
$23.6B
$6.55M 0.8%
66,517
+6,240
+10% +$642K
SWKS icon
46
Skyworks Solutions
SWKS
$9.22B
$6.16M 0.75%
55,679
-12,026
-18% -$1.27M
EXP icon
47
Eagle Materials
EXP
$6.59B
$6.15M 0.75%
32,993
+2,899
+10% +$462K
PLD icon
48
Prologis
PLD
$135B
$5.6M 0.68%
45,698
+886
+2% +$109K
CFR icon
49
Cullen/Frost Bankers
CFR
$10.5B
$5.59M 0.68%
52,026
+18,510
+55% +$1.93M
CTAS icon
50
Cintas
CTAS
$81.6B
$5.37M 0.65%
43,228
-1,372
-3% -$161K

Similar funds

Callahan Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Callahan Advisors held 142 positions worth $823M, up 6.3% from $774M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Callahan Advisors's Q2 2023 filing shows 7 new, 62 increased, 51 reduced and 9 closed positions. Its largest new stake was Dow Inc: 71,050 shares worth $3.78M. The largest sale was DuPont de Nemours, an estimated $4.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Callahan Advisors's largest Q2 2023 buy was Dow Inc: 71,050 shares worth $3.78M.
  • Callahan Advisors added most to Brookfield in Q2 2023, an estimated $2.26M increase.
  • Callahan Advisors's biggest Q2 2023 reduction was AbbVie, cutting an estimated $4.01M.
  • Callahan Advisors fully exited DuPont de Nemours in Q2 2023, selling an estimated $4.2M.
  • Callahan Advisors's ten largest holdings make up 32% of its $823M portfolio in Q2 2023.
  • Callahan Advisors opened 7 new positions and closed 9 in Q2 2023.
  • Callahan Advisors's portfolio value rose 6.3% quarter-over-quarter to $823M.

Based on Callahan Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.